Author:
Deb Barnali,Kumar Prashant
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Gondkar K, Patel K, Krishnappa S, Patil A, Nair B, Sundaram GM, Zea TT, Kumar P (2019) E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma. Cancer Biomark 25:223–232.
https://doi.org/10.3233/CBM-190013
2. McConkey DJ, Choi W (2018) Molecular subtypes of bladder cancer. Curr Oncol Rep 20:77.
https://doi.org/10.1007/s11912-018-0727-5
3. Sharma J, Deb B, George IA, Kapil S, Coral K, Kakkar N, Pattanaik S, Mandal AK, Mavuduru RS, Kumar P (2019) Somatic mutations profile of a young patient with metastatic urothelial carcinoma reveals mutations in genes involved in ion channels. Front Oncol 9:435.
https://doi.org/10.3389/fonc.2019.00435
4. Thomsen MB, Nordentoft I, Lamy P, Hoyer S, Vang S, Hedegaard J, Borre M, Jensen JB, Orntoft TF, Dyrskjot L (2016) Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma. Mol Oncol 10:1450–1460.
https://doi.org/10.1016/j.molonc.2016.08.003
5. Simon R, Eltze E, Schafer KL, Burger H, Semjonow A, Hertle L, Dockhorn-Dworniczak B, Terpe HJ, Bocker W (2001) Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61:355–362